TY - JOUR AU - Liu, Z. AU - Zhou, Y. AU - Zhang, P. AU - Qin, H. PY - 2010 DA - 2010// TI - Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma JO - Surg Laparosc Endosc Percutan Tech VL - 20 UR - https://doi.org/10.1097/SLE.0b013e3181d823df DO - 10.1097/SLE.0b013e3181d823df ID - Liu2010 ER - TY - STD TI - Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F, Yang J. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol. 2010;10:78. ID - ref2 ER - TY - STD TI - Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252(6):903–12. ID - ref3 ER - TY - STD TI - Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology-Basel. 2007;72 Suppl 1:98–103. ID - ref4 ER - TY - STD TI - Nakazawa T, Kokubu S, Shibuya A, Ono K, Watanabe M, Hidaka H, Tsuchihashi T, Saigenji K. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol. 2007;188(2):480–8. ID - ref5 ER - TY - STD TI - Okuwaki Y, Nakazawa T, Shibuya A, Ono K, Hidaka H, Watanabe M, Kokubu S, Saigenji K. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk f actors and patterns. J Gastroenterol. 2008;43(1):71–8. ID - ref6 ER - TY - STD TI - Mori K, Fukuda K, Asaoka H, Ueda T, Kunimatsu A, Okamoto Y, Nasu K, Fukunaga K, Morishita Y, Minami M. Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study. Radiology. 2009;251(2):557–65. ID - ref7 ER - TY - STD TI - Tokunaga S, Koda M, Matono T, Sugihara T, Nagahara T, Ueki M, Murawaki Y, Kakite S, Yamashita E. Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. Br J Radiol. 2012;85(1014):745–52. ID - ref8 ER - TY - STD TI - Okubo H, Kokubu S, Komiyama M, Yamagata H, Uchiyama A, Miyazaki A, Watanabe S. Radiofrequency ablation of hepatocellular carcinoma: The feasibility of magnetic resonance imaging with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid for evaluating the ablative margin. Hepatol Res. 2010;40(10):1034–41. ID - ref9 ER - TY - STD TI - Makino Y, Imai Y, Igura T, Hori M, Fukuda K, Sawai Y, Kogita S, Ohama H, Matsumoto Y, Nakahara M, Zushi S, Kurokawa M, Isotani K, Takamura M, Fujita N, Murakami T. Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression. Hepatol Res. 2013;43(9):950–8. ID - ref10 ER - TY - JOUR AU - Kim, Y. AU - Lee, W. J. AU - Rhim, H. AU - Lim, H. K. AU - Choi, D. AU - Lee, J. Y. PY - 2010 DA - 2010// TI - The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion JO - Am J Roentgenol VL - 195 UR - https://doi.org/10.2214/AJR.09.2954 DO - 10.2214/AJR.09.2954 ID - Kim2010 ER - TY - JOUR AU - Sakakibara, M. AU - Ohkawa, K. AU - Katayama, K. AU - Imanaka, K. AU - Ishihara, A. AU - Hasegawa, N. AU - Kimura, H. PY - 2014 DA - 2014// TI - Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy JO - Am J Roentgenol VL - 202 UR - https://doi.org/10.2214/AJR.13.11384 DO - 10.2214/AJR.13.11384 ID - Sakakibara2014 ER - TY - STD TI - Zhong-Zhen S, Kai L, Rong-Qin Z, Er-Jiao X, Ting Z, Ao-Hua Z, Shu-Fang Y, Xu-Qi H. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall Med. 2012;33(7):E250–5. ID - ref13 ER - TY - STD TI - Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11–29. ID - ref14 ER - TY - JOUR AU - Dill-Macky, M. J. AU - Asch, M. AU - Burns, P. AU - Wilson, S. PY - 2006 DA - 2006// TI - Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography JO - AJR Am J Roentgenol VL - 186 UR - https://doi.org/10.2214/AJR.04.1916 DO - 10.2214/AJR.04.1916 ID - Dill-Macky2006 ER - TY - STD TI - Mauri G, Porazzi E, Cova L, Restelli U, Tondolo T, Bonfanti M, Cerri A, Ierace T, Croce D, Solbiati L. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5(2):209–16. ID - ref16 ER - TY - JOUR AU - Meloni, M. F. AU - Andreano, A. AU - Franza, E. AU - Passamonti, M. AU - Lazzaroni, S. PY - 2012 DA - 2012// TI - Contrast enhanced ultrasound: Should it play a role in immediate evaluation of liver tumors following thermal ablation? JO - Eur J Radiol VL - 81 UR - https://doi.org/10.1016/j.ejrad.2012.05.002 DO - 10.1016/j.ejrad.2012.05.002 ID - Meloni2012 ER - TY - STD TI - Jung EM, Friedrich C, Hoffstetter P, Dendl LM, Klebl F, Agha A, Wiggermann P, Stroszcynski C, Schreyer AG. Volume navigation with contrast enhanced ultrasound and image fusion for percutaneous interventions: first results. PLoS One. 2012;7(3):e33956. ID - ref18 ER - TY - STD TI - Krucker J, Xu S, Venkatesan A, Locklin JK, Amalou H, Glossop N, Wood BJ. Clinical utility of real-time fusion guidance for biopsy and ablation. J Vasc Interv Radiol. 2011;22(4):515–24. ID - ref19 ER - TY - STD TI - Lee MW, Rhim H, Cha DI, Kim YJ, Choi D, Kim YS, Lim HK. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012;198(6):1438–44. ID - ref20 ER - TY - STD TI - Liu FY, Yu XL, Liang P, Cheng ZG, Han ZY, Dong BW, Zhang XH. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol. 2012;81(7):1455–9. ID - ref21 ER - TY - STD TI - Ukimura O, Desai MM, Palmer S, Valencerina S, Gross M, Abreu AL, Aron M, Gill IS. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol. 2012;187(3):1080–6. ID - ref22 ER - TY - JOUR AU - Bruix, J. AU - Sherman, M. PY - 2011 DA - 2011// TI - Management of hepatocellular carcinoma: an update JO - Hepatology VL - 53 UR - https://doi.org/10.1002/hep.24199 DO - 10.1002/hep.24199 ID - Bruix2011 ER - TY - STD TI - Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N, Sakamoto M. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer. 2002;95(9):1931–7. ID - ref24 ER - TY - STD TI - Ikeda K, Seki T, Umehara H, Inokuchi R, Tamai T, Sakaida N, Uemura Y, Kamiyama Y, Okazaki K. Clinicopathologic study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy. Int J Oncol. 2007;31(3):485–91. ID - ref25 ER -